🔗 Share this article

Ex-government leader Rishi Sunak has strengthened his appeal for a targeted screening programme for prostate cancer.

During a recent discussion, he declared being "certain of the urgency" of implementing such a system that would be economical, deliverable and "protect countless lives".

These comments come as the British Screening Authority reconsiders its ruling from five years ago not to recommend routine screening.

Journalistic accounts suggest the authority may maintain its existing position.

Athlete Adds Voice to Campaign

Champion athlete Sir Chris Hoy, who has advanced prostate cancer, wants younger men to be tested.

He suggests decreasing the age threshold for accessing a PSA blood screening.

Currently, it is not standard practice to healthy individuals who are younger than fifty.

The PSA examination remains debated nevertheless. Levels can rise for reasons other than cancer, such as inflammation, resulting in misleading readings.

Critics maintain this can lead to unnecessary treatment and adverse effects.

Focused Testing Proposal

The suggested examination system would target males between 45 and 69 with a genetic predisposition of prostate gland cancer and men of African descent, who experience increased susceptibility.

This population comprises around over a million males in the United Kingdom.

Organization calculations propose the programme would cost twenty-five million pounds per year - or about eighteen pounds per individual - similar to colorectal and mammary cancer examination.

The projection includes 20% of suitable candidates would be notified annually, with a seventy-two percent response rate.

Diagnostic activity (scans and tissue samples) would need to expand by twenty-three percent, with only a reasonable growth in healthcare personnel, based on the analysis.

Clinical Professionals Reaction

Various clinical specialists are sceptical about the benefit of examination.

They argue there is still a chance that patients will be treated for the cancer when it is not strictly necessary and will then have to live with complications such as bladder issues and impotence.

One respected urological expert stated that "The issue is we can often detect disease that might not necessitate to be treated and we potentially create harm...and my apprehension at the moment is that negative to positive ratio needs adjustment."

Individual Perspectives

Patient voices are also affecting the discussion.

A particular example features a 66-year-old who, after seeking a prostate screening, was identified with the cancer at the age of fifty-nine and was informed it had spread to his pelvic area.

He has since experienced chemotherapy, radiation treatment and hormone treatment but cannot be cured.

The individual endorses examination for those who are genetically predisposed.

"That is very important to me because of my sons – they are 38 and 40 – I want them screened as soon as possible. If I had been examined at fifty I am confident I wouldn't be in the position I am now," he stated.

Future Actions

The Medical Screening Authority will have to assess the information and viewpoints.

Although the latest analysis indicates the consequences for staffing and capacity of a screening programme would be feasible, some critics have contended that it would redirect scanning capacity from patients being cared for for alternative medical problems.

The ongoing discussion highlights the multifaceted trade-off between timely diagnosis and likely overtreatment in prostate cancer treatment.